Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. 2002

Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
Department of Medicine, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia. michael.horowitz@adelaide.edu.au

OBJECTIVE The effect of erythromycin on gastric emptying is attenuated during hyperglycaemia. The aim of this study was to determine in patients with diabetic gastroparesis whether the effect of cisapride on gastric emptying of solids and liquids is influenced by the plasma glucose concentration. METHODS Nineteen patients with type 1 diabetes mellitus, who had delayed gastric emptying of solids and/or liquids, were studied. On 2 separate days, each patient received cisapride (20 mg) or placebo orally 60 min before scintigraphic measurement of gastric emptying of a mixed solid (ground beef) and liquid (dextrose) meal. The plasma glucose concentrations were measured at -5, 30, 60, 90, and 120 min during each gastric emptying measurement. RESULTS Cisapride accelerated both solid (retention at 100 min 43 +/- 4 vs. 69 +/- 4%, p < 0.001) and liquid (T50 27 +/- 2 vs. 39 +/- 2 min, p < 0.001) gastric emptying. The mean plasma glucose level was not significantly different after placebo when compared with cisapride (19.5 +/- 1.1 vs. 18.2 +/- 1.0 mmol/l). The change in the 50% emptying time (T50) for liquid, but not solid, emptying was related (r = 0.55, p = 0.01) to the change in the plasma glucose AUC from 0 to 30 min between the placebo and cisapride tests, i.e., the acceleration was greater if the plasma glucose concentration was relatively less during the gastric emptying test performed on cisapride. CONCLUSIONS The effect of cisapride on gastric emptying, at least that of liquids, in patients with diabetic gastroparesis appears to be dependent on the plasma glucose concentration.

UI MeSH Term Description Entries
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D005746 Gastric Emptying The evacuation of food from the stomach into the duodenum. Emptying, Gastric,Emptyings, Gastric,Gastric Emptyings
D005765 Gastrointestinal Agents Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. Digestants,Gastric Agents,Gastric Drugs,Gastrointestinal Drugs,Agents, Gastric,Agents, Gastrointestinal,Drugs, Gastric,Drugs, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D018589 Gastroparesis Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS. Gastric Stasis,Gastric Stases,Gastropareses,Stases, Gastric,Stasis, Gastric

Related Publications

Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
February 1994, Gut,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
October 1999, The American journal of gastroenterology,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
April 1990, Nihon Heikatsukin Gakkai zasshi,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
June 1988, Deutsche medizinische Wochenschrift (1946),
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
January 2018, Journal of diabetes research,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
January 1993, European journal of clinical pharmacology,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
May 2000, Alimentary pharmacology & therapeutics,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
January 1988, Nihon Heikatsukin Gakkai zasshi,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
November 1998, The Journal of pharmacology and experimental therapeutics,
Michael Horowitz, and Karen L Jones, and Philip E Harding, and Judith M Wishart
November 2016, Neurogastroenterology and motility,
Copied contents to your clipboard!